The 10-year commitment to support Gavi vaccine programmes is part of Norway’s US$ 1 billion commitment to Gavi
London, 8 May 2020 – Norway has committed an additional US$ 400 million over the next 10 years to the International Finance Facility for Immunisation (IFFIm), which leverages long-term donor financing
Fast, flexible financing could be a game-changer in fighting the virus
As COVID-19 cases mount around the world, scientists are pulling out all the stops to find a safe and viable vaccine. G20 leaders have pledged to “do whatever it takes” to combat the deadly virus.
Finance executive brings deep experience of public and private sector funding
London, 19 March 2020 – Jessica Pulay has been appointed to the Board of Directors of IFFIm, the International Finance Facility for Immunisation, and will serve a three-year term effective 1 April 2020.
London, 16 March 2020 - Participants from 13 organizations ranging from legal and investment firms to Gavi, IFFIm, Red Cross, the UN and the World Bank gathered in central London on March 2 to explore creating a forum for public and private users of innovative finance.
London, 6 February 2020 -- IFFIm, Skandinaviska Enskilda Banken (SEB) and the Toronto-Dominion Bank have been awarded SRI “Deal of the Year” by news, data and analytics publisher mtn-i for a July 2019 Vaccine Bond issuance that raised funding to resear
A conversation with Christopher Egerton-Warburton
Christopher Egerton-Warburton, or Edge, as he’s known throughout the financial world, was in the room where it happened, when IFFIm began in 2006. Edge is the Co-Founder and Partner of Lion's Head Global Partners LLP and served for six years on the IFFIm Board of Directors.
From an acclaimed debut Uridashi to the latest investment by Dai-ichi Life, Japanese investors set a trend for socially responsible investing
Leaders from the global health community are convening this week at the